§ 22-11A-16 — Serologic or Other Biologic Sample Required to Be Taken of Pregnant Women and of Newborns

Alabama § 22-11A-16

• Jurisdiction: Alabama
• Title 22: Health, Mental Health, and Environmental Control
• Ch. 11A: Reporting Notifiable Diseases
• Art. 1: General Provisions

Text

(a) Every physician or other person permitted by law to attend a pregnant woman during gestation shall, in the case of each woman so attended, take or cause to be taken any serologic or other biologic sample of the woman as provided by the State Board of Health. Any sample shall be submitted to a laboratory approved by the board for testing for those sexually transmitted diseases for which there exists an effective vaccine or curative treatment approved by the federal Food and Drug Administration and as provided by the board.
(b) Every physician or other person permitted by law to attend a pregnant woman during delivery shall take or cause to be taken any serologic or other biologic sample of the woman and any newborn as provided by the State Board of Health. Any sample shall be submitted to a laboratory approved by the board for testing for those sexually transmitted diseases for which there exists an effective vaccine or curative treatment approved by the federal Food and Drug Administration and as provided by the board.
(c) All positive or reactive tests shall be reported as provided in Section 22-11A-14.

Legislative History

(Acts 1987, No. 87-574, p. 904, §16; Acts 1990, No. 90-629, p. 1148, §2; Act 2004-246, p. 338, §1.)